AGNPF
Price
$0.04
Change
-$0.01 (-20.00%)
Updated
Aug 29 closing price
Capitalization
1.74M
KYMR
Price
$40.69
Change
-$0.51 (-1.24%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
2.95B
58 days until earnings call
Interact to see
Advertisement

AGNPF vs KYMR

Header iconAGNPF vs KYMR Comparison
Open Charts AGNPF vs KYMRBanner chart's image
Algernon Pharmaceuticals
Price$0.04
Change-$0.01 (-20.00%)
Volume$400
Capitalization1.74M
Kymera Therapeutics
Price$40.69
Change-$0.51 (-1.24%)
Volume$28.65K
Capitalization2.95B
AGNPF vs KYMR Comparison Chart in %
Loading...
AGNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGNPF vs. KYMR commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGNPF is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (AGNPF: $0.04 vs. KYMR: $41.20)
Brand notoriety: AGNPF and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGNPF: 2% vs. KYMR: 82%
Market capitalization -- AGNPF: $1.74M vs. KYMR: $2.95B
AGNPF [@Biotechnology] is valued at $1.74M. KYMR’s [@Biotechnology] market capitalization is $2.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGNPF’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • AGNPF’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both AGNPF and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGNPF’s TA Score shows that 3 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • AGNPF’s TA Score: 3 bullish, 6 bearish.
  • KYMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than AGNPF.

Price Growth

AGNPF (@Biotechnology) experienced а -22.60% price change this week, while KYMR (@Biotechnology) price change was -6.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.95B) has a higher market cap than AGNPF($1.74M). KYMR YTD gains are higher at: 2.411 vs. AGNPF (-13.607). AGNPF has higher annual earnings (EBITDA): -1.73M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. AGNPF (88.2K). KYMR has higher revenues than AGNPF: KYMR (44.7M) vs AGNPF (0).
AGNPFKYMRAGNPF / KYMR
Capitalization1.74M2.95B0%
EBITDA-1.73M-267.03M1%
Gain YTD-13.6072.411-564%
P/E Ratio2.22N/A-
Revenue044.7M-
Total Cash88.2K665M0%
Total DebtN/A85.7M-
FUNDAMENTALS RATINGS
AGNPF: Fundamental Ratings
AGNPF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGNPFKYMR
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
76%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
73%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
AGNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHINX13.510.01
+0.07%
Centre Global Infrastructure Investor
IRMTX10.28-0.03
-0.29%
Voya Russell Mid Cap Index Port S2
GSXCX28.23-0.09
-0.32%
abrdn US Small Cap Equity C
CSMUX25.67-0.12
-0.47%
Carillon Scout Mid Cap R-6
HCAIX112.94-1.47
-1.28%
Harbor Capital Appreciation Inv

AGNPF and

Correlation & Price change

A.I.dvisor tells us that AGNPF and CGEN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGNPF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGNPF
1D Price
Change %
AGNPF100%
-19.48%
CGEN - AGNPF
23%
Poorly correlated
+0.71%
CYDY - AGNPF
21%
Poorly correlated
-4.47%
VIVS - AGNPF
21%
Poorly correlated
+30.48%
ABCZF - AGNPF
10%
Poorly correlated
N/A
KYMR - AGNPF
8%
Poorly correlated
-1.32%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.32%
NRIX - KYMR
67%
Closely correlated
-0.74%
VERA - KYMR
58%
Loosely correlated
-2.92%
CGON - KYMR
56%
Loosely correlated
+0.39%
LYRA - KYMR
53%
Loosely correlated
-0.71%
IDYA - KYMR
53%
Loosely correlated
-1.52%
More